Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack "PERFORM"

Recruiting

Phase N/A Results N/A

Summary of Purpose

To demonstrate the superiority of terutroban over a marketed drug (antithrombotic agent) in reducing the number of cerebrovascular and cardiovascular events in patients with cerebrovascular diseases.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 November 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Institut de Recherches Internationales Servier (France)

Trial Design

Randomized, double-blind, parallel-group study

Contacts

Not available